Business
First Patient of Cohort 2 Dosed in MND Trial
First Patient of Cohort 2 Dosed in MND Trial
About this update from Neurizon Therapeutics Limited
[{"type":"text","content":"Neurizon Therapeutics Limited has released a press release. View Attachment","length":243,"tagName":"div"}]